Validation of the TNM classification (4th edn) for lung cancer: first results of a prospective study of 1086 patients with surgical treatment

Abstract
For the purpose of testing the validity of the new TNM classification(fourth edition) for lung cancer, data from 1086 patients with surgicaltreatment were analysed prospectively. Several items were examined: (1) theagreement between clinical (TNM) and pathologically confirmedclassification (pTNM); (2) the value of the various diagnostic tests inestimating the pathologically confirmed classification; (3) the influenceof the TNM definitions on separating distinct prognostic groups. Withregard to the primary tumour (T), clinical and pathological classificationwere identical in 64% of the cases. With regard to lymph node involvement(N), the agreement was 48%, for distant metastasis 90% and for the staging55%. As for the primary tumour (T), the accuracy of radiography (59%) wasnearly identical with that of computed tomography (58%). Both thesediagnostic techniques were less precise in determining the extent of lymphnode involvement (computed tomography 50% correct assessments, radiography43%). The statistically significant differences in the prognoses for thevarious pT, pN and pM categories as well as for the pathological stages andthe categories of the new R classification could be confirmed. The new 1987TNM definitions for lung cancer make possible international conformity; theclassification is also practically useful and the prognostic relevanceimproved. The new classifications thus provide a more reliable basis forestablishing guidelines for individual oncological therapy strategies andfor the exchange of information between different centres on the progressmade in diagnosis and therapy of lung cancer.

This publication has 0 references indexed in Scilit: